(ABAX) Abaxis announces CLIA waived status for two additional medical test panels.
(AMZN) Amazon.com’s partnership at Borders is being terminated.
(ARWR) Arrowhead Research subsidiary Unidym to merge with Carbon Nanotechnologies for $5.4 million worth of ARWR common stock.
(BGP) Borders Group sees losses because of charges on closing Walden Books locations; ends distribution pact with Amazon.com.
(BVX) Bovie Medical reports Q4 EPS of $0.02.
(CAG) ConAgra $0.38 EPS vs $0.35e.
(CBST) Cubist Pharma licenses rights for development and commercialization of Cubicin in Japan to Merck.
(CRXL) Crucell announces influenza alliance with ADImmune.
(EBS) Emergent Biosolutions announces the promotion of Daniel Kramer to President.
(FLE) Fleetwood is in a modular housing supply pact with the US Army.
(GIS) General Mills $0.73 EPS vs $0.70e.
(GLGC) Gene Logic names new CEO.
(IAO) IA Global board approved a 4 million share buyback.
(ICFI) ICF International awarded $22.1 million contract with the FAA.
(MOD) Modine Manufacturing sees Q4 EPS be at or below the break-even level.
(MNST) Monster Worldwide says online recruitment activity rises in top 28 US metro markets in February; not a surprise after you saw the newspaper numbers drop.
(MOT) Motorola lowered guidance; accelerated share buyback; made management changes (not Zander).
(NMX) NYMEX trading up 1% after 7 million shares priced at $136.50 for secondary.
(RTN) Raytheon raised dividend; stock lower on Goldman Sachs downgrade.
(SPPI) Spectrum Pharma study said that patients treated with Satraplatin demonstrated statistically significant improvement in pain response.
(TRIS) Tri-s Security subsidiary awarded $6.4 million contracts with FAA.
(TWTR) Tweeter will consolidate in restructuring pact; closing 49 stores and exit certain regions; will have 20% layoffs.
(USEY) US Energy Sys signs agreement with Illinois Commerce Commission enabling its reorganization to proceed with creditor support.
(VQ) Venoco signs agreements to acquire fields in Texas and California.
(WSM) William Sonoma boosts dividend and announced 5 million share buyback plan; $1.06 EPS vs $1.03e.
(ZOLL) ZOLL Medical receives marketing clearance for M Series with real CPR help technology.
Jon C. Ogg
March 22, 2007
Top Gaining Stocks
Top Losing Stocks